| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Medicus Pharma Ltd.
13G/A
MDCX · 58471K202
|
4.5% |
8/12/2025
Event 6/30/2025
|
||||
| John Hathaway | 4.5% | |||||
| SkinJect Partners LLC | 4.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.